Clinical Trial Update: Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update. It reports outcomes for colorectal cancer patients with liver metastases treated with the FOLFOX-4 chemotherapy regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN